Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Asthma Clinical criteria: Patient must be unable to use this drug delivered from an oral pressurised inhalation device via a spacer.
Chronic obstructive pulmonary disease (COPD) Clinical criteria: Patient must be unable to use this drug delivered from an oral pressurised inhalation device via a spacer.
“Ipratropium bromide pressurised inhalation aerosol is an anticholinergic bronchodilator. It appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagal nerve.”
“The half-life of the terminal elimination phase is about 1.6 hours.”
Working under the parallel aged-care framework? Aged-care equivalent →
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.